Breast Cancer | Specialty

The OncLive Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Dr. Kubicky on the Optimal Use of Radiation in Patients With Breast Cancer

May 29th 2018

Charlotte Kubicky, MD, PhD, associate professor of radiation medicine, School of Medicine, medical director, Tuality Oregon Health and Science Cancer Center, Oregon Health and Science University, discusses the optimal use of radiation in the treatment of patients with breast cancer.

Expert Recaps Adjuvant Advancements in HER2+ Breast Cancer

May 24th 2018

Haythem Y. Ali, MD, discusses adjuvant advances in HER2-postitive breast cancer and emerging agents in the field.

Dr. Jhaveri on Acquired Resistance to CDK 4/6 Inhibitors in Breast Cancer

May 24th 2018

Komal L. Jhaveri, MD, FACP, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses acquired resistance to CDK 4/6 inhibitors in breast cancer.

Dr. Newman on Advances in Axillary Surgery in Breast Cancer

May 22nd 2018

Lisa A. Newman, MD, director, Breast Oncology Program, Henry Ford Cancer Institute, discusses advances in axillary surgery for the treatment of patients with node-positive breast cancer.

Dr. Simon on Genomic Assays for Patients With Breast Cancer

May 22nd 2018

Michael Simon, MD, MPH, medical oncologist, Karmanos Cancer Institute, discusses genomic assays for patients with breast cancer.

Dr. Walker on the Use of Radiation Therapy in Patients With Breast Cancer

May 22nd 2018

Eleanor M. Walker, MD, senior staff physician, division director, Breast Services in the Department of Radiation Oncology, Henry Ford Cancer Institute, discusses the use of radiation therapy in patients with breast cancer.

Experts Discuss Frontline CDK4/6 Inhibitors in ER+ Breast Cancer

May 19th 2018

Dennis J. Slamon, MD, PhD, and Sara A. Hurvitz, MD, discuss the impact of CDK4/6 inhibitors in ER-positive breast cancer.

Expert Addresses Optimal Use of Endocrine Therapy in HR+ Breast Cancer

May 10th 2018

Rena D. Callahan, MD, discusses controversies in the management of early-stage HR-positive breast cancer and neoadjuvant trial designs for these patients.

Link Between Diet and Breast Cancer Recurrence Risk Still Unknown

May 9th 2018

Aashini Master, DO, discusses efforts to integrate nutrition and health into breast cancer survivorship.

Dr. Master on the Mediterranean Diet in Relation to Breast Cancer Risk

May 8th 2018

Aashini Master, DO, assistant clinical professor, Division of Hematology/Oncology, University of California, Los Angeles Medical Center, discusses the Mediterranean diet in relation to breast cancer risk.

Expert Explains State of Surgery in Nonmetastatic Breast Cancer

May 7th 2018

Maggie DiNome, MD, discusses the evolution of surgical approaches in patients with early-stage breast cancer.

HER2+ Breast Cancer Outlook Improved, But More Work Remains

May 5th 2018

Kelly McCann, MD, PhD, discusses the therapies available for patients with HER2-positive breast cancer and the potential benefit with additional subtyping in the field.

Dr. Chagpar Discusses Benefit of Primary Tumor Surgery in Breast Cancer

May 3rd 2018

Anees B. Chagpar, MD, FACS, associate professor, Department of Surgery, Yale School of Medicine, assistant director, Global Oncology, Yale Comprehensive Cancer Center, discusses the potential benefit of primary tumor surgery for patients with breast cancer.

Postoperative Radiation in Breast Cancer Now a Personalized Process

May 2nd 2018

Susan A. McCloskey, MD, discusses the use of postoperative radiation in patients with breast cancer.

CDK4/6 Inhibition Refined in HR+ Breast Cancer, as Novel Combos Emerge

May 1st 2018

Sara Hurvitz, MD, shares insight on the 3 CDK4/6 inhibitors approved in HR-positive breast cancer, and looks toward the future of these agents, which will likely include combination strategies.

Dr. Soliman on Investigational Combination Therapies in Patients With Breast Cancer

April 30th 2018

Hatem Soliman, MD, medical oncologist, The Center for Women’s Oncology, Moffitt Cancer Center, discusses the use of combination therapies in the treatment of patients with breast cancer.

What Can We Learn From "Extreme Survivors" of Breast Cancer?

April 29th 2018

Mark Burkard, MD, PhD, discusses an unusual study launched at the University of Wisconsin.

Dr. Brufsky on Multiparametric Genomic Assays in Breast Cancer

April 28th 2018

Adam M. Brufsky, MD, PhD, professor of Medicine, associate chief of Hematology/Oncology, co-director of the Comprehensive Breast Care Center, associate director of Clinical Investigation, University of Pittsburgh, discusses multiparametric assays in breast cancer.

Dr. McCloskey on Postoperative Radiation in Patients With Breast Cancer

April 27th 2018

Susan A. McCloskey, MD, MSHS, assistant professor of radiation oncology, University of California Los Angeles (UCLA) Medical Center, Jonsson Comprehensive Cancer Center, discusses the evolution of postoperative radiation in patients with breast cancer.

Expert Encourages Adjuvant Endocrine Therapy in Premenopausal Breast Cancer

April 26th 2018

Reshma L. Mahtani, DO, discusses the use of adjuvant endocrine therapy in premenopausal breast cancers, specifically the use of ovarian function suppression and GnRH agonists.